Point Biomedical Corp.
This article was originally published in Start Up
Executive Summary
Biomaterials. Point Biomedical's expertise is in biodegradable polymers, tailored for {in vivo} residence time, biological reactivity and tissue integration properties. The company is developing ultrasound contrast agents, a urological drug delivery implant, and surgical adhesives with improved handling and tissue integration properties.